ERT is a global data and technology company that minimizes uncertainty and risk in clinical trials. For nearly 50 years ERT has been balancing the knowledge of what works with a vision for what’s next, adapting without compromising standards. Since 2014, more than half of all FDA drug approvals came from ERT-supported studies. By identifying trial risks before they become problems, ERT enables customers to bring clinical treatments to patients quickly — and with confidence.
With an understanding that better medicine begins with better disease models, Xylyx developed the IN MATRICO™ Lung Fibrosis Assay Platform – a standardized cell-based IPF model that enables drug candidates to be assayed in human fibrotic lung extracellular matrix (ECM) substrates. The IN MATRICO™ Platform also provides patient-specific clinical data corresponding to the human lung ECM to facilitate data interpretation, closing the gap between preclinical and clinical studies in order to accelerate the identification and advancement of effective anti-fibrotic drugs.
Nordic Bioscience is a world-leading biomarker extracellular matrix specialist, which offers customized development of highly disease-specific biochemical markers for diagnosis and prognosis of various diseases. All this creating a new generation of Precision Medicine. Our goal is to assist our clients developing targeted treatments faster within Fibrosis, Immunology/Rheumatology and Oncology, more effectively, at a lower cost and with a more favorable risk-benefit ratio for patients and our clients through highly specialized biomarker services.
Aragen Bioscience is a leading contract research organization, focused on accelerating antibody and other large-molecule preclinical development. Our integrated service offerings include: cell line development, protein expression, protein purification, process development, cell-based assays, biophysical assays, and in vivo models of disease. We are based in the San Francisco Bay Area.
Celebrating 20 years of scientific excellence, IPS Therapeutique (IPST) is a Contract Research Organization dedicated to the preclinical evaluation of the efficacy and safety of new drugs using validated and highly predictive models. At IPST we believe each study is worthy of tailored protocols designed to maximize the scientific and strategic value of the data generated. We believe in taking ownership of the studies entrusted to IPST while ensuring mutual collaboration for developing and agreeing to overall project plans. You can learn more about our story by watching this video.
Vitalograph Clinical Trials teams are highly qualified professionals, with an in-depth understanding of all the requirements for respiratory testing, both as end-points or for safety data in clinical trials, and in particular the challenges of regulatory compliance.
Our customized, personal service is made possible by Vitalograph having formed an experienced and responsive team, providing dedicated project and data managers, software development engineers, internationally renowned over-readers, in-house QA and logistic specialists, plus full manufacturing and 24/7 support capabilities.